| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.091 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | RG-108 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.082 | 0.02 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.41 | 0.02 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | navitoclax:birinapant (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |